SYNTHESIS: A solution of 10.0 g
A solution of 17.0 g of 1-(2,5-dimethoxyphenyl)-2-nitropropene was prepared in 500 mL anhydrous Et2O. This solution was added slowly to a well-stirred suspension of 12.0 g LAH in 700 mL anhydrous Et2O. The mixture was then brought up to a reflux and maintained there for 20 h, cooled with an external ice bath, and the excess hydride destroyed by the cautious addition of H2O. Finally, a total of 500 mL H2O was added, followed by the addition of 300 g potassium sodium tartrate, and sufficient aqueous NaOH to bring the pH above 9. The two phases were separated, and the ether phase dried by the addition of anhydrous MgSO4. The drying agent was removed by filtration, and the clear filtrate saturated with a stream of anhydrous HCl gas. The formed crystals of 2,5-dimethoxyamphetamine hydrochloride (2,5-DMA) were removed by filtration, washed with anhydrous Et2O, and dried to constant weight of 16.3 g. Recrystallization from EtOH gave an analytical sample with a mp of 114–116 °C. The hydrobromide salt is reported to melt at 129–131 °C.
DOSAGE: 80–160 mg.
DURATION: 6–8 h.
EXTENSIONS AND COMMENTARY: The qualitative information on 2,5-DMA is very sparse. I was up to a 1+ with 80 milligrams of the hydrochloride, and since it appeared to be totally a physical trip with tremors and some cardiovascular push and nothing of a sensory nature, I chose to explore it no further. A report from South America found the intoxication to be largely pleasant (this, at 75 milligrams), with an enhanced interest in one’s surroundings, but no perceptual changes, no overt stimulation, and no gross physiological effects other than a slight mydriasis (dilation of the pupils). I have also been told of a single trial of 250 milligrams of the tartrate (this is equivalent to somewhere in the 150–200 milligram range of the hydrochloride salt, depending upon the acid/base ratio of the tartrate salt) with some “speedy” effects but still no sensory changes. A seizure of capsules reported by the drug law enforcement authorities some 20 years ago found that each contained some 200 milligrams of the hydrobromide salt. This is equivalent to 170 milligrams of the hydrochloride salt, and suggests that level may be an effective dosage.
An intriguing, but little studied, analogue of 2,5-DMA is the compound with methyls in place of the methoxyls.
All three isomers of monomethylamphetamine have also been looked at in man. The ortho- and meta-isomers,
There is a mystery, at least to me, concerning the commercial production of 2,5-DMA. At regular intervals, there is a public announcement of the production quotas that are requested or allowed by the Drug Enforcement Administration, for drugs that have been placed in Schedules I or II. In the Schedule I category there are usually listed amounts such as a gram of this, and a few grams of that. These are probably for analytical purposes, since there are no medical uses, by definition, for drugs in this Schedule. But there is a staggering quantity of 2,5-DMA requested, regularly. Quantities in the many tens of millions of grams, quantities that vie with medical mainstays such as codeine and morphine. I have heard that this material is used in the photographic industry, but I have no facts. Somewhere I am sure that there is someone who has to keep a lot of very careful books!
In the area of psychedelic drugs, the value of 2,5-DMA is mainly in its role as a precursor to the preparation of materials that can come from a direct electrophilic attack on the activated 4-position. These uses can be found under things such as
However, the study of various direct iodinations and fluoridations that would have the N,N-dimethyl substitution on the amphetamine nitrogen atom, would require the 4-proteo- analogue, and this was made from the above nitrostyrene. A solution of the above nitrostyrene, 22.3 g 1-(2,5-dimethoxyphenyl)-2-nitropropene in 100 mL acetic acid was added to a suspension of elemental iron in acetic acid (45 g in 250 mL) and worked up with water and base washing to give, after distillation at 92–106 °C at 0.35 mm/Hg, 13.8 g 2,5-dimethoxyphenylacetone as a pale yellow oil. This underwent reductive amination with dimethylamine hydrochloride in MeOH solution, using sodium cyanoborohydride, to give the target compound 2,5-dimethoxy-N,N-dimethylamphetamine oxalate with a melting point of 133–134 °C (4.6 g ketone gave 1.38 g of salt). Anal. (C15H23NO6) C,H. It has also been prepared by the N,N-dimethylation of 2,5-DMA directly, with formaldehyde and formic acid. This has been called
All of these latter materials remain unevaluated in man.
1 Nov 2018 · · Isomer Design
About PiHKAL · info
This version of Book II of PiHKAL is based on the Erowid online version, originally transcribed by Simson Garfinkle and converted into HTML by Lamont Granquist. I drew also on “Tyrone Slothrop’s” (Unfinished) Review of PIHKAL to enumerate the many analogues mentioned in PiHKAL but not described at length. Many, many others have since been added.
I have tried here to expunge any artifacts introduced by the earlier transcriptions and restore the typographic niceties found in the printed edition. I’ve also made minor changes to some chemical names in line with current nomenclature practice. Typically the change is little more than expanding a prefix or setting it in italics. The history page has further details.
“At the present time, restrictive laws are in force in the United States and it is very difficult for researchers to abide by the regulations which govern efforts to obtain legal approval to do work with these compounds in human beings.“No one who is lacking legal authorization should attempt the synthesis of any of the compounds described in these files, with the intent to give them to man. To do so is to risk legal action which might lead to the tragic ruination of a life. It should also be noted that any person anywhere who experiments on himself, or on another human being, with any of the drugs described herein, without being familiar with that drug’s action and aware of the physical and/or mental disturbance or harm it might cause, is acting irresponsibly and immorally, whether or not he is doing so within the bounds of the law.”
The copyright for Book I of PiHKAL has been reserved in all forms and it may not be distributed. Book II of PiHKAL may be distributed for non-commercial reproduction provided that the introductory information, copyright notice, cautionary notice and ordering information remain attached.
PiHKAL is the extraordinary record of the authors’ years exploring the chemistry and transformational power of phenethylamines. This book belongs in the library of anyone seeking a rational, enlightened and candid perspective on psychedelic drugs.
Though Sasha and Ann have put Book II of PiHKAL in the public domain, available to anyone, I strongly encourage you to buy a copy. We owe them — and there’s still nothing quite like holding a real book in your hands.
PiHKAL (ISBN 0-9630096-0-5) is available for US$24.50 (plus $10 domestic first-class shipping) from Transform Press.Transform Press,
Berkeley, CA 94701
510 · 934 · 4930 (voice)
510 · 934 · 5999 (fax)